Skip to main content
37 articles related to "Xelox"

Articles

Study Protocol

Published on 31 Oct 2023

Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study)

in Cancer Immunity and Immunotherapy

  • Yizhang Chen
  • Jiaguang Zhang
  • Gaohua Han
  • Jie Tang
  • Fen Guo
  • Wei Li
  • Li Xie
  • Hao Xu
  • Xinyi Zhang
  • Yitong Tian
Frontiers in Immunology
doi 10.3389/fimmu.2023.1232858
  • 4,392 views
  • 6 citations